Ustekinumab Improves Active Crohn's Disease by Suppressing the T Helper 17 Pathway.
Ihara Y, Torisu T, Miyawaki K, Umeno J, Kawasaki K, Hirano A, Fujioka S, Fuyuno Y, Matsuno Y, Sugio T, Sasaki K, Moriyama T, Akashi K, Kitazono T.
Ihara Y, et al.
Digestion. 2021;102(6):946-955. doi: 10.1159/000518103. Epub 2021 Jul 22.
Digestion. 2021.
PMID: 34350861